AN2 Therapeutics (ANTX)

• Market cap: $32.9M
• 1 day: -4%
• 5 days: -8.4%
• 1 month: 3.45%
• 3 months: 1.69%
• 6 months: 11.11%
• Year to date: 8.11%
• 1 year: -5.51%
• 5 years: -92.21%
• 10 years: -92.21%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Employees: 36